Tim Walbert, Horizon CEO via YouTube
Horizon hits the gas pedal on renewed early-stage R&D, enlisting a Mitch Gold biotech in a $1.5B+ deal
Horizon Therapeutics is no stranger to swinging deals, and on Thursday the Irish biotech grabbed itself a new partner to help build out its early …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
